Envestnet Asset Management Inc. Has $1.22 Million Stock Holdings in Heska Co. (NASDAQ:HSKA)

Envestnet Asset Management Inc. grew its position in shares of Heska Co. (NASDAQ:HSKAGet Rating) by 14.3% in the 2nd quarter, Holdings Channel reports. The firm owned 12,947 shares of the medical research company’s stock after acquiring an additional 1,621 shares during the quarter. Envestnet Asset Management Inc.’s holdings in Heska were worth $1,224,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in the company. Northwestern Mutual Wealth Management Co. raised its holdings in Heska by 132.0% during the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 232 shares of the medical research company’s stock worth $32,000 after purchasing an additional 132 shares during the last quarter. Teacher Retirement System of Texas raised its holdings in Heska by 7.4% during the 1st quarter. Teacher Retirement System of Texas now owns 2,124 shares of the medical research company’s stock worth $294,000 after purchasing an additional 147 shares during the last quarter. Teachers Retirement System of The State of Kentucky increased its stake in shares of Heska by 5.2% in the 1st quarter. Teachers Retirement System of The State of Kentucky now owns 3,057 shares of the medical research company’s stock valued at $423,000 after acquiring an additional 150 shares in the last quarter. US Bancorp DE increased its stake in shares of Heska by 6.3% in the 2nd quarter. US Bancorp DE now owns 5,015 shares of the medical research company’s stock valued at $474,000 after acquiring an additional 295 shares in the last quarter. Finally, Point72 Hong Kong Ltd bought a new stake in shares of Heska in the 1st quarter valued at $57,000. Institutional investors own 97.39% of the company’s stock.

Heska Price Performance

HSKA opened at $62.66 on Wednesday. The company has a debt-to-equity ratio of 0.24, a current ratio of 7.18 and a quick ratio of 5.61. The company has a market capitalization of $678.36 million, a price-to-earnings ratio of -39.91 and a beta of 1.45. The firm’s fifty day moving average price is $72.69 and its two-hundred day moving average price is $84.99. Heska Co. has a 1 year low of $58.00 and a 1 year high of $189.37.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on HSKA. JPMorgan Chase & Co. lowered their price objective on shares of Heska from $175.00 to $150.00 and set an “overweight” rating for the company in a research note on Monday, October 17th. Alliance Global Partners lowered their price objective on shares of Heska from $155.00 to $119.00 and set a “buy” rating for the company in a research note on Wednesday, November 9th. Morgan Stanley lowered their price objective on shares of Heska from $149.00 to $135.00 and set an “equal weight” rating for the company in a research note on Wednesday, November 9th. Piper Sandler lowered their price objective on shares of Heska from $170.00 to $165.00 and set an “overweight” rating for the company in a research note on Monday, November 14th. Finally, StockNews.com began coverage on shares of Heska in a research note on Wednesday, October 12th. They issued a “hold” rating for the company. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $142.25.

About Heska

(Get Rating)

Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers.

Further Reading

Want to see what other hedge funds are holding HSKA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Heska Co. (NASDAQ:HSKAGet Rating).

Institutional Ownership by Quarter for Heska (NASDAQ:HSKA)

Receive News & Ratings for Heska Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heska and related companies with MarketBeat.com's FREE daily email newsletter.